Cargando…

Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis

Persons at clinical high-risk for psychosis (CHR) are characterised by specific neurocognitive deficits. However, the course of neurocognitive performance during the prodromal period and over the onset of psychosis remains unclear. The aim of this meta-analysis was to synthesise results from follow-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedges, Emily P., See, Cheryl, Si, Shuqing, McGuire, Philip, Dickson, Hannah, Kempton, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386433/ https://www.ncbi.nlm.nih.gov/pubmed/35821623 http://dx.doi.org/10.1017/S0033291722001830

Ejemplares similares

M154. INTRA- AND INTER-SCANNER RELIABILITY OF GRAY MATTER VOLUME AND CORTICAL THICKNESS ESTIMATES: IMPLICATIONS FOR MULTICENTRE IMAGING STUDIES IN PSYCHOSIS
por: Hedges, Emily, et al.
Publicado: (2020)

Reliability of structural MRI measurements: The effects of scan session, head tilt, inter-scan interval, acquisition sequence, FreeSurfer version and processing stream
por: Hedges, Emily P, et al.
Publicado: (2022)

How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
por: Kempton, Matthew J., et al.
Publicado: (2015)

Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2021)

Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis
por: Catalan, Ana, et al.
Publicado: (2022)

Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis
por: Cullen, Alexis E., et al.
Publicado: (2019)

Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis: A Systematic Review and Meta-analysis
por: Blackman, Graham, et al.
Publicado: (2023)

Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome
por: Hird, Emily J, et al.
Publicado: (2022)

Neural correlates of emotional processing in psychosis risk and onset – A systematic review and meta-analysis of fMRI studies
por: Lukow, P.B., et al.
Publicado: (2021)

F220. THREAT ANTICIPATION AND NEGATIVE AFFECT IN EARLY PSYCHOSIS
por: Chavez-Baldini, UnYoung, et al.
Publicado: (2018)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Meta-analysis of associations between childhood adversity and hippocampus and amygdala volume in non-clinical and general population samples
por: Calem, Maria, et al.
Publicado: (2017)

Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study
por: Paetzold, Isabell, et al.
Publicado: (2021)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

Cingulate activity and fronto-temporal connectivity in people with prodromal signs of psychosis
por: Allen, Paul, et al.
Publicado: (2010)

Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis
por: Antoniades, Mathilde, et al.
Publicado: (2018)

The Placebo Effect in Psychosis: Why It Matters and How to Measure It
por: Hird, Emily J., et al.
Publicado: (2023)

F71. THE STRUCTURE OF NEUROCOGNITION ACROSS CHILDHOOD AND ADULTHOOD IN YOUNG PEOPLE WITH PSYCHOSIS.
por: Mollon, Josephine, et al.
Publicado: (2018)

Differential trajectories of tobacco smoking in people at ultra-high risk for psychosis: Associations with clinical outcomes
por: Schirmbeck, Frederike, et al.
Publicado: (2022)

Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
por: Hermans, Karlijn S. F. M., et al.
Publicado: (2021)

S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY
por: Richter, Anja, et al.
Publicado: (2020)

Impact of physiological factors on longitudinal structural MRI measures of the brain
por: Zahid, Uzma, et al.
Publicado: (2022)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
por: Catalan, Ana, et al.
Publicado: (2022)

Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis
por: Tognin, Stefania, et al.
Publicado: (2023)

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
por: Sami, Musa, et al.
Publicado: (2020)

Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Cortisol Responses to Naturally Occurring Psychosocial Stressors Across the Psychosis Spectrum: A Systematic Review and Meta-Analysis
por: Cullen, Alexis E., et al.
Publicado: (2020)

Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape
por: Sami, Musa, et al.
Publicado: (2020)

Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis
por: Reilly, Thomas J, et al.
Publicado: (2020)

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
por: Tognin, Stefania, et al.
Publicado: (2022)

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
por: Pollak, Thomas A., et al.
Publicado: (2020)

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis
por: Mechelli, Andrea, et al.
Publicado: (2017)

Theory of mind and neurocognition in early psychosis: a quasi-experimental study
por: Langdon, Robyn, et al.
Publicado: (2014)

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis
por: Schirmbeck, Frederike, et al.
Publicado: (2021)

Psychosis and substance abuse increase the COVID-19 mortality risk
por: Catalan, Ana, et al.
Publicado: (2023)

Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study
por: Kerins, Sarah, et al.
Publicado: (2022)

Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis
por: Schmidt, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o1tcoaid2q1lner7mgki07k47i